Impact Factor Journals
Design, Synthesis, and Biological Evaluation of 2-Hydroxy-4-phenylthiophene-3-carbonitrile as PD-L1 Antagonist and Its Comparison to Available Small Molecular PD-L1 Inhibitors. Journal of Medicinal Chemistry. 2023, 66(14), 9577-9591, ISSN: 0022-2623, PMID: 37450644,
2,4-Diaryl-pyrimido[1,2-a]benzimidazole derivatives as novel anticancer agents endowed with potent anti-leukemia activity: Synthesis, biological evaluation and kinase profiling. European Journal of Medicinal Chemistry. 2023, 258, 115610, ISSN: 0223-5234, PMID: 37437350,
Hyperoside as a UV Photoprotective or Photostimulating Compound-Evaluation of the Effect of UV Radiation with Selected UV-Absorbing Organic Compounds on Skin Cells. International Journal of Molecular Sciences. 2023, 8(24), 9910, ISSN: 1422-0067 , PMID: 37373060,
Increased blood reactive oxygen species and hepcidin in obstructive sleep apnea precludes expected erythrocytosis. American Journal of Hematology. 2023, 98(8), 1265-1276, ISSN: 0361-8609 , PMID: 37350302.
Clinical and prognostic significance of detecting CEA, EGFR, LunX, c-met and EpCAM mRNA-positive cells in the peripheral blood, tumor-draining blood and bone marrow of non-small cell lung cancer patients. Translational Lung Cancer Research. 2023, 12(5), 1034-1050, ISSN: 2226-4477 , PMID: 37323172,
New use of Old Drugs: Repurposing of Non-oncology Drugs for Cancer and Oncology Drugs for other Human Diseases. Anti-cancer Agents in Medicinal Chemistry. 2023, 23(10), 1103, ISSN: 1871-5206, PMID: 37271990,